Universitetssykehuset Nord-Norge HF

Research activity also covers major depression in adults with co-occurring alcohol use disorder, particularly among patients receiving addiction treatment. The clinical focus is on mood symptoms in the setting of substance-related illness and the management of complex psychiatric comorbidity.

• Dual diagnosis psychiatry
• Addiction therapy
• Ketamine treatment

This area reflects interest in interventions for patients whose depressive disorders and alcohol-related problems overlap in inpatient and specialist care.

The sponsor supports studies in ulcerative colitis, with emphasis on early disease management and outcomes in newly diagnosed patients. The research centers on identifying severe disease patterns and tailoring treatment strategies for gastrointestinal inflammation.

• Inflammatory bowel disease
• Biologic therapy
• Deep remission

Clinical interest includes stratified care for patients at high risk of poor outcomes in colorectal inflammatory disease.

The funded studies reflect a strong interest in applying established treatments to defined patient groups across psychiatry, addiction medicine, and gastroenterology. Research activity is concentrated in Tromsø and the health region of Northern Norway, with a focus on clinically relevant interventions in specialist hospital care.

• Specialist hospital research
• Patient subgroup identification
• Clinical translation

The sponsor’s research portfolio spans mental health and immune-mediated disease, with practical relevance for hospital-based treatment pathways.